Akero Therapeutics Inc (AKRO)
28.92
+0.36
(+1.26%)
USD |
NASDAQ |
Dec 26, 12:09
Akero Therapeutics Free Cash Flow: -212.64M for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Madrigal Pharmaceuticals Inc | -438.32M |
| 89bio Inc | -280.54M |
| NovaBay Pharmaceuticals Inc | -4.812M |
| Palatin Technologies Inc | -32.57M |
| iBio Inc | -16.93M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -70.42M |
| Cash from Investing (Quarterly) | 73.07M |
| Cash from Financing (Quarterly) | 3.067M |
| Free Cash Flow Per Share (Quarterly) | -1.014 |
| Free Cash Flow Yield | -11.59% |